Radboudumc and Eindhoven University of Technology present: BIOTRIP. This independent biotech incubator aims to ensure human health through cutting edge biotech. BIOTRIP is a unique platform that brings together medical scientists and entrepreneurial biomedical engineers to work with biotech entrepreneurs. They develop, commercialize and make available vaccines and immunotherapies to patients with a variety of diseases.
Related news items
Aftermovie Investment Day 2022 and a new date for 2023!
13 December 2022Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.
read more
Successful matchmaking at Radboudumc Investment Day
7 October 2022On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.
read more
Radboudumc Investment Day 2022
26 September 2022Get ready for Radboudumc Investment Day 2022: October 5 in Nijmegen!
read more
Xenikos enrolls first patient in global pivotal phase 3 study evaluating T-Guard®
30 June 2022 First patient dosed in their Phase 3 study for T-Guard, a candidate for the treatment of severe acute graft-versus-host disease (aGVHD). read more
Simmunext: where immunotherapy and chemistry meet
2 June 2022 The story behind Radboud university medical center’s, Radboud University’s and Oncode’s newest spinoff, Simmunext Biotherapeutics B.V. read more